Skeptical Traders Wait for Proof<br />By Rev Shark<br />RealMoney.com Contributor<br />7/18/2008 9:02 AM EDT <br /><br />A faith that hasn't been tested can't be trusted. <br /><br />--Adrian Rogers <br /><br />A strong earnings report from Citibank (C) is undoing much of the damage that was done by poor reports last night from Google (GOOG) , Microsoft (MSFT) and Merrill Lynch (MER) . Even a bounce in crude oil isn't enough to keep the S&P 500 and Dow Jones Industrial Average down, as the market continues to embrace the idea that maybe this time the worst really is over. <br /><br />Ideally, what the market should see at this point is a mild pullback, some basing action to digest recent gains, and then strong follow through to indicate that there are some real buyers out there. <br /><br />At the moment, we have a good bounce from badly oversold conditions, but nothing to really give us confidence that a lasting bottom is in. When we pull back, as we certainly will at some point, the real test of this bounce will come. We need buyers to show that they have faith and are willing to jump in when emotions start to cool as the impact of the recent good news is no longer as fresh. <br /><br />Even though the indices have been up strongly two days in a row, the action has been extremely chaotic with some dramatic swings in sector leadership. The sectors that have been the strongest for many months, oil, steel, coal, solar energy, agriculture, etc., were destroyed Thursday, as financials delivered a huge short squeeze and drove up the indices. The only way to have kept pace with the indices was to have been fully invested in banks and brokers, which has not been a smart play for over a year. <br /><br />When the market puts together a big bounce like it has the last couple days, it can cause a lot of conflicting emotions for the active market player. If you have been playing defense and holding cash, the great likelihood is that you have underperformed the market the last few days. <br /><br />While the press and the usual perma-bulls are celebrating and acting like we can only go straight up from here, the prudent trader is still skeptical and waiting for proof. At this point, we should be starting to look for better technical patterns that we might embrace IF the market continues to show signs that a lasting turn is in play. <br /><br />The market has had the benefit of being very oversold just as some key earnings reports hit. The combination delivered a very good bounce, but this is the point now where we need the buyers to show that they really are ready to put more cash to work. <br /><br />Citibank is trumping a lot of issues from last night, and we will see how well we hold once we open. Obviously, the relief over banks and brokers is great, and we'll see if the market really believes that the worst is over there. <br /><br />We are certainly not out of the woods, but we have a good start. It is now up to the bulls to do the work needed to keep things going. While we can be a bit more optimistic, we can't be too trusting. <br />------------------------------<br />Ülespoole avanevad:<br /><br />In reaction to strong earnings/guidance: MAT +14.9%, WTS +8.8%, CBST +8.5%, C +7.2%, TPX +6.9%, WERN +6.4% (upgraded to Neutral at JPMorgan), IGTE +5.7%, SWKS +4.1%, HON +3.7%, SLB +2.3%, VMI +1.5%, ICUI +1.2%... M&A news: BRL +8.3% (to be acquired by TEVA for $66.50/share)... Select mortgage/financials showing continued strength: DSL +8.2% (continued momentum following yesterday's 40%+surge), FNM +7.0%, WB +5.2%, RBS +5.2%, BCS +3.6%, HBC +2.3%, CS +2.0%, UBS +1.8%, STI +1.2%... Other news: PNCL +17.1% (Pinnacle Airlines, Delta reach agreement), MDVN +10.2% (announced publication of results of its first Alzheimer's disease pivotal clinical trial of the investigational drug Dimebon), ALU +5.4% (still checking), SMA +4.4% (Cramer makes positive comments), SPWR +3.0% (discloses that Emmanuel Hernandez has communicated his intent to retire as Chief Financial Officer), GSK +2.6%, PCX +2.2% (will replace CBRL in the S&P MidCap 400), SNY +2.0% (Zentiva rejects $1.92 bln Sanofi-Aventis bid as too low- DJ), CLF +1.8% (Harbinger Capital reports 18.36% stake in 13D filing; Opposes merger with Alpha)... Analyst comments: UAUA +8.5% (upgraded to Overweight at JPMorgan), VSE +5.0% (upgraded to Buy at UBS), SPWR +2.6% (upgraded to Buy at Broadpoint Capital), WPPGY +2.5% (upgraded to Buy at Citigroup), RDY +1.9% (upgraded to Buy at Goldman - DJ), YUM +1.4% (upgraded to Outperform at Wachovia), MRK +1.2% (initiated with Buy at Citigroup).<br /><br />Allapoole avanevad:<br /><br />In reaction to disappointing earnings/guidance: SFI -15.3%, ESLR -10.9%, MAN -7.4% (light volume), AMD -7.0%, GILD -6.9% (also downgraded to Hold at Jefferies and downgraded to Market Perform from Outperform at BMO), GOOG -6.9% (also downgraded to Accumulate at ThinkPanmure), WIT -6.4%, MSFT -5.1%, INDB -4.4% (light volume), CIEN -3.0%, SAY -2.4% (light volume), SYK -2.1%, MER -2.1% (also Moody's Downgrades Merrill Lynch To A2, Stable Outlook and downgraded to Underperform from In Line at Fox Pitt), PMCS -1.9%, COF -1.6%... M&A news: ANR -3.7% (CLF's largest shareholder opposes merger with ANR), RSG -2.3% (declines to enter merger negotiations with Waste Management; says remains committed to Allied Waste Transaction)... Other news: SGLP -31.2% (confirms co's parent is experiencing liquidity issues and is exploring various alternatives; also downgraded to Hold at Citigroup), TSL -5.2% (still checking), AMZN -3.3% (still checking)... Analyst comments: HBAN -2.9% (downgraded to In Line from Outperform at Fox Pitt), SMTS -2.6% (downgraded to Hold at Citigroup), TSO -2.2% (downgraded to Market Perform at Bernstein), IGT -2.1% (downgraded to Hold at Citigroup and downgraded to Perform at Oppenheimer), NVS -1.1% (downgraded to Hold at Societe Generale - Bloomberg).